Biodexa Pharmaceuticals Plc (BDRX) NASDAQ

1.03

+0.2337(+29.35%)

Updated at June 18 04:00PM

Currency In USD

Valuation

Market Cap2,654.43
Enterprise Value-939,345
P/E Ratio-0
PEG Ratio-0
Price/Sales Ratio0.01
Price/Book Ratio0
Enterprise/Revenue-11.34
Enterprise/EBITDA0.17

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterDecember 31, 2024

Profitability

Profit Margin-82.16
Operating Margin-96.3

Management Effectiveness

Return On Assets-0.46
Return On Equity-0.8

Income Statement

Revenue381,000
Revenue/Share0.25
Gross Profit-3.69M
EBITDA-7.16M
Net Income-7.08M
Diluted EPS-89,652

Balance Sheet

Total Cash1.67M
Total Cash/Share5.09
Total Debt727,000
Total Debt/Equity0.09
Current Ratio1.75
Book Value Per Share25.37

Price History

52-Week Change-95.84
52-Week High41.5
52-Week Low0.79
Moving Average 50 Days1.3
Moving Average 200 Days4.06

Statistics

Average Volume2.48M
Shares Outstanding820
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:25
Last Split DateOctober 04, 2024